EPILEPSYGTX LIMITED
Company number 13415161 · Monitor this company
Executive summary
EpilepsyGTx Limited exhibits high solvency risk with negative working capital and minimal cash reserves at its first year-end. While regulatory filings are current and the company benefits from institutional shareholder support and experienced directors, the absence of operational revenue and limited financial history warrant close examination of funding and business viability before investment. Further due diligence on recent financials and strategic plans is essential to assess the company’s future stability.
Shareholders' funds
-£4,953
Balance sheet as at 2021-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-05-24
- Employees
- 0 (2021 accounts)
- Registered office
- Camburgh House, 27 New Dover Road, Canterbury, Kent, United Kingdom, CT1 3DN
- Postcode
- CT1 3DN
- Capital
- 200 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-05-23
- Next due by
- 2027-06-06
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 6 current · 4 resigned
Group structure
Controlled by UTF GENERAL PARTNER 2 LLP — since 2025-02-10
Controlled by UCL VENTURES LIMITED — since 2022-05-24
From persons-with-significant-control filings on the public register.
Data protection registration
Registered with the ICO as a data protection fee payer — ZC206138 (Tier 1), registered since 2026.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Competitors Canterbury
This company ranks 21 among research and experimental development on biotechnology in Canterbury.